Eastman Chemical Company (EMN)
Official siteBASIC MATERIALS • SPECIALTY CHEMICALS • NYSE
Market Cap: $7.43B
Last updated: Nov 17, 2026 at 11:05 AM ET
Eastman Chemical Company (EMN) Stock Forecast
Analysts expect Eastman Chemical Company (EMN) to earn $6.11 per share in the fiscal year ending Dec 31, 2026, on revenue of $9.22B. Of 17 analysts, 8 rate the stock Buy or Strong Buy, 9 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 12 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 17 ratings average 2.41, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 47% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 2 | 11.8% |
| Buy | 6 | 35.3% |
| Hold | 9 | 52.9% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 17
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 6.7% and revenue estimates rise 2.4%.
- Fiscal year ending Dec 31, 2026
- $6.11
- EPS consensus, revenue $9.22B
- Fiscal year ending Dec 31, 2027
- $6.52
- EPS consensus, revenue $9.44B
- Next report
- Jan 27, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $6.11 | $6.00 to $6.34 | 15 | $9.22B | $9.03B to $9.32B | 14 |
| Dec 31, 2027 | $6.52 | $5.70 to $6.91 | 16 | $9.44B | $8.98B to $9.79B | 14 |
Quarterly Estimates
The EPS consensus rises from $1.20 for the quarter ending Dec 31, 2026 to $1.40 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $1.20 | $1.08 to $1.34 | 19 | $2.18B | $2.02B to $2.36B | 15 |
| Mar 31, 2027 | $1.40 | $1.17 to $1.53 | 7 | $2.31B | $2.23B to $2.43B | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 3 upward and 14 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 12 |
| Quarter ending Mar 31, 2027 | 2 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has fallen 4.4% from $6.39.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $6.11 | $6.30 | $6.36 | $6.39 | $6.39 | -4.4% |
| Fiscal year ending Dec 31, 2027 | $6.52 | $6.64 | $6.84 | $6.93 | $6.93 | -5.9% |
| Quarter ending Mar 31, 2027 | $1.40 | $1.43 | $1.46 | $1.47 | $1.47 | -5.2% |
Frequently Asked Questions About EMN
What is the EMN stock forecast?
Consensus analyst estimates put Eastman Chemical Company's EPS at $6.11 for the fiscal year ending Dec 31, 2026, on revenue of $9.22B. The consensus rating from 17 analysts is Buy.
How do analysts rate EMN stock?
Of 17 analysts covering Eastman Chemical Company, 2 rate it Strong Buy, 6 Buy, 9 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from EMN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $6.11, with estimates from $6.00 to $6.34 from 15 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $6.52, with estimates from $5.70 to $6.91 from 16 analysts.
What revenue do analysts expect from Eastman Chemical Company next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $9.22B, with estimates from $9.03B to $9.32B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.44B, with estimates from $8.98B to $9.79B.
How many analysts cover EMN?
17 analysts rate Eastman Chemical Company stock, and 15 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
EMN pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors